Clinical remission after biologic therapy discontinuation in pediatric patients with severe asthma: a case series from a tertiary center
Author:
Affiliation:
1. 1. Universidade Federal de Ciências da Saúde de Porto Alegre – UFCSPA – Porto Alegre (RS) Brasil.
2. 2. Pontifícia Universidade Católica do Rio Grande do Sul – PUCRS – Porto Alegre (RS) Brasil.
Publisher
Sociedade Brasileira de Pneumologia e Tisiologia
Reference9 articles.
1. 1. Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention. Bethesda: GINA; 2022.
2. 2. Nieto García A, Garriga-Baraut T, Plaza Martín AM, Nieto Cid M, Torres Borrego J, Folqué Giménez MDM, et al. Omalizumab outcomes for up to 6 years in pediatric patients with severe persistent allergic asthma. Pediatr Allergy Immunol. 2021;32(5):980-991. https://doi.org/10.1111/pai.13484
3. 3. Normansell R, Walker S, Milan SJ, Walters EH, Nair P. Omalizumab for asthma in adults and children. Cochrane Database Syst Rev. 2014;2014(1):CD003559. https://doi.org/10.1002/14651858.CD003559.pub4
4. 4. Menzies-Gow A, Bafadhel M, Busse WW, Casale TB, Kocks JWH, Pavord ID, et al. An expert consensus framework for asthma remission as a treatment goal. J Allergy Clin Immunol. 2020;145(3):757-765. https://doi.org/10.1016/j.jaci.2019.12.006
5. 5. Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma [published correction appears in Eur Respir J. 2014 Apr;43(4):1216. Dosage error in article text] [published correction appears in Eur Respir J. 2018 Jul 27;52(1):] [published correction appears in Eur Respir J. 2022 Jun 9;59(6):]. Eur Respir J. 2014;43(2):343-373. https://doi.org/10.1183/09031936.00202013
Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Omalizumab/unspecified corticosteroids;Reactions Weekly;2024-07-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3